human fibroblast growth factor 2 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
96
Structured Review
R&D Systems
human fibroblast growth factor 2
Human Fibroblast Growth Factor 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 899 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fibroblast+growth+factor+2+fgf2/Recombinant+Human+FGF+basic%2FFGF2%2FbFGF+(146+aa)+Protein/pm41978430-44-25-30
Average 96 stars, based on 899 article reviews
Human Fibroblast Growth Factor 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 899 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fibroblast+growth+factor+2+fgf2/Recombinant+Human+FGF+basic%2FFGF2%2FbFGF+(146+aa)+Protein/pm41978430-44-25-30
Average 96 stars, based on 899 article reviews
human fibroblast growth factor 2 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Cell Culture:Article Title: A novel junctional epithelial cell line, mHAT-JE01, derived from incisor epithelial cells. Article Snippet: Objectives: Junctional epithelium (JE) connects the tooth surface and gingival epithelium and adheres directly to the tooth enamel.. JE plays an important role as a barrier preventing the invasion of exogenous bacteria and substances.. However, the cellular characteristics of this epithelium have not been adequately described, because no useful in vitro experimental model exists for JE. Article Title: CDX2 Promotes Hepatic Specification of hiPSC-derived Endoderm Through the PI3K-Akt-GSK3β Pathway for Improved Therapeutic Efficacy. Article Snippet: Hepatobiliary diseases impose a considerable burden on human health.. Approximately 2 million people die each year, accounting for 4% of the global mortality [1, 2].. Conventional treatment methods such as liver transplantation and drug therapy have certain effects. Article Title: Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations. Article Snippet: FGFR1 amplification and FGFR1/2 activating mutations have been associated with antiestrogen resistance in estrogen receptor-positive (ER+) breast cancer.. However, there are no approved FGFR1-targeted therapies for breast cancers harboring these alterations.. In this study, we investigated the selective degradation of FGFR1/2 using the proteolysis-targeting chimera (PROTAC) DGY-09-192 as a novel therapeutic strategy in ER + breast cancers harboring FGFR1/2 somatic alterations. Modification:Article Title: A novel junctional epithelial cell line, mHAT-JE01, derived from incisor epithelial cells. Article Snippet: Objectives: Junctional epithelium (JE) connects the tooth surface and gingival epithelium and adheres directly to the tooth enamel.. JE plays an important role as a barrier preventing the invasion of exogenous bacteria and substances.. However, the cellular characteristics of this epithelium have not been adequately described, because no useful in vitro experimental model exists for JE. Generated:Article Title: 3D flexible self-folding microelectrode array for organoid electrophysiology analysis Article Snippet: Cell Biomaterials 1, 100179, December 23, 2025 9 the open-source Open Ephys GUI software (Open Ephys) with low-pass filtering (1–300 Hz) and high-pass filtering (300– 6,000 Hz) and processed using MATLAB. .. EMLOC gastruloids were generated through a four-stage protocol described previously.38,39 Briefly, in stage 1, 2D hiPSC colonies at approximately 50%–60% confluence were induced for 48 h in induction medium, comprising N2B27 basal medium (1:1 DMEM/F-12 [Thermo Fisher Scientific, cat# 11320033] and Neurobasal Plus [Thermo Fisher Scientific, cat# A3582901] supplemented with 2% [v/v] B-27 [Thermo Fisher Scientific, cat# 17504044], 1% [v/v] N-2 [Thermo Fisher Scientific, cat# 17502048], 1× GlutaMAX [Thermo Fisher Scientific, cat# 35050061], and 1× MEM non-essential amino acids [Thermo Fisher Scientific, cat# 11140050]) with 3 μM 6-[[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl] amino]ethyl]amino]-3-pyridinecarbonitrile (CHIR 99021, Tocris Bioscience, cat# 4423) and 40 ng/mL of Single Cell:Article Title: 3D flexible self-folding microelectrode array for organoid electrophysiology analysis Article Snippet: Cell Biomaterials 1, 100179, December 23, 2025 9 the open-source Open Ephys GUI software (Open Ephys) with low-pass filtering (1–300 Hz) and high-pass filtering (300– 6,000 Hz) and processed using MATLAB. .. EMLOC gastruloids were generated through a four-stage protocol described previously.38,39 Briefly, in stage 1, 2D hiPSC colonies at approximately 50%–60% confluence were induced for 48 h in induction medium, comprising N2B27 basal medium (1:1 DMEM/F-12 [Thermo Fisher Scientific, cat# 11320033] and Neurobasal Plus [Thermo Fisher Scientific, cat# A3582901] supplemented with 2% [v/v] B-27 [Thermo Fisher Scientific, cat# 17504044], 1% [v/v] N-2 [Thermo Fisher Scientific, cat# 17502048], 1× GlutaMAX [Thermo Fisher Scientific, cat# 35050061], and 1× MEM non-essential amino acids [Thermo Fisher Scientific, cat# 11140050]) with 3 μM 6-[[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl] amino]ethyl]amino]-3-pyridinecarbonitrile (CHIR 99021, Tocris Bioscience, cat# 4423) and 40 ng/mL of Suspension:Article Title: 3D flexible self-folding microelectrode array for organoid electrophysiology analysis Article Snippet: Cell Biomaterials 1, 100179, December 23, 2025 9 the open-source Open Ephys GUI software (Open Ephys) with low-pass filtering (1–300 Hz) and high-pass filtering (300– 6,000 Hz) and processed using MATLAB. .. EMLOC gastruloids were generated through a four-stage protocol described previously.38,39 Briefly, in stage 1, 2D hiPSC colonies at approximately 50%–60% confluence were induced for 48 h in induction medium, comprising N2B27 basal medium (1:1 DMEM/F-12 [Thermo Fisher Scientific, cat# 11320033] and Neurobasal Plus [Thermo Fisher Scientific, cat# A3582901] supplemented with 2% [v/v] B-27 [Thermo Fisher Scientific, cat# 17504044], 1% [v/v] N-2 [Thermo Fisher Scientific, cat# 17502048], 1× GlutaMAX [Thermo Fisher Scientific, cat# 35050061], and 1× MEM non-essential amino acids [Thermo Fisher Scientific, cat# 11140050]) with 3 μM 6-[[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl] amino]ethyl]amino]-3-pyridinecarbonitrile (CHIR 99021, Tocris Bioscience, cat# 4423) and 40 ng/mL of Derivative Assay:Article Title: Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells. Article Snippet: Accepted Manuscript Title: Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells Author: Hu Yao Qu Zhuang-yin Cao Shi-ying Li Qi Ma Lixiang Robert Krencik Xu Min Liu Yan PII: S0165-0270(16)30023-1 DOI: http://dx.doi.org/doi:10.1016/j.jneumeth.2016.03.017 Reference: NSM 7485 To appear in: Journal of Neuroscience Methods Received date: 13-1-2016 Revised date: 27-3-2016 Accepted date: 28-3-2016 Please cite this article as: Hu Yao, Qu Zhuang-yin, Cao Shi-ying, Li Qi, Ma Lixiang, Krencik Robert, Xu Min, Liu Yan.Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells.Journal of Neuroscience Methods http://dx.doi.org/10.1016/j.jneumeth.2016.03.017 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Knock-Out:Article Title: Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells. Article Snippet: Accepted Manuscript Title: Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells Author: Hu Yao Qu Zhuang-yin Cao Shi-ying Li Qi Ma Lixiang Robert Krencik Xu Min Liu Yan PII: S0165-0270(16)30023-1 DOI: http://dx.doi.org/doi:10.1016/j.jneumeth.2016.03.017 Reference: NSM 7485 To appear in: Journal of Neuroscience Methods Received date: 13-1-2016 Revised date: 27-3-2016 Accepted date: 28-3-2016 Please cite this article as: Hu Yao, Qu Zhuang-yin, Cao Shi-ying, Li Qi, Ma Lixiang, Krencik Robert, Xu Min, Liu Yan.Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells.Journal of Neuroscience Methods http://dx.doi.org/10.1016/j.jneumeth.2016.03.017 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Recombinant:Article Title: Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells. Article Snippet: Accepted Manuscript Title: Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells Author: Hu Yao Qu Zhuang-yin Cao Shi-ying Li Qi Ma Lixiang Robert Krencik Xu Min Liu Yan PII: S0165-0270(16)30023-1 DOI: http://dx.doi.org/doi:10.1016/j.jneumeth.2016.03.017 Reference: NSM 7485 To appear in: Journal of Neuroscience Methods Received date: 13-1-2016 Revised date: 27-3-2016 Accepted date: 28-3-2016 Please cite this article as: Hu Yao, Qu Zhuang-yin, Cao Shi-ying, Li Qi, Ma Lixiang, Krencik Robert, Xu Min, Liu Yan.Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells.Journal of Neuroscience Methods http://dx.doi.org/10.1016/j.jneumeth.2016.03.017 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. |
